申请人:——
公开号:US20040229847A1
公开(公告)日:2004-11-18
The present invention is concerned among others with compounds of formula (I), the N-oxides, the pharmaceutically acceptable addition salts, the quaternary amines and stereochemically isomeric forms thereof, wherein Q is halo, C
1-6
alkyl or C
2-6
alkenyl; X is (a-2) with q and r being O and Z being O, S or SO; R
1
is aryl; R
2
is selected from formyl; C
1-6
alkyloxycarbonylalkyl; Het
2
; Het
2
C
1-6
alkyl, C
1-6
alkylthio; C
1-6
alkyl optionally substituted with one or two substituents each independently selected from hydroxy, and halo; R
3
is selected from formyl; C
1-6
alkyl optionally substituted with one or two C
1-6
alkyloxy; R
1
is hydrogen, with HTV inhibiting properties.
1
本发明涉及式(I)的化合物,其N-氧化物,药学上可接受的加成盐,季铵盐和立体化学异构体形式,其中Q是卤素,C1-6烷基或C2-6烯基; X为(a-2),其中q和r为O,Z为O,S或SO; R1为芳基; R2选自甲酰基; C1-6烷氧羰基烷基; Het2; Het2C1-6烷基,C1-6烷基硫醚; C1-6烷基,可选用一个或两个取代基,独立地选自羟基和卤素; R3选自甲酰基; C1-6烷基,可选用一个或两个C1-6烷氧基; R1为氢,具有HTV抑制性能。